APA

Saez-Carlin P., García-Botella A., Diez-Valladares L. I., Ortega Medina L., Méndez R., González J. C. M., Bernal I., Serrano García I., Avellana R. & Torres García A. J. (20210325). Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM). : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Chicago

Saez-Carlin P, García-Botella A, Diez-Valladares L I, Ortega Medina L, Méndez R, González J C M, Bernal I, Serrano García I, Avellana R and Torres García A J. 20210325. Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM). : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Harvard

Saez-Carlin P., García-Botella A., Diez-Valladares L. I., Ortega Medina L., Méndez R., González J. C. M., Bernal I., Serrano García I., Avellana R. and Torres García A. J. (20210325). Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM). : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

MLA

Saez-Carlin P, García-Botella A, Diez-Valladares L I, Ortega Medina L, Méndez R, González J C M, Bernal I, Serrano García I, Avellana R and Torres García A J. Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM). : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20210325.